Cargando…
Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer
The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different human tumors. Therefore, the aim of this study was...
Autores principales: | Cerquetti, Lidia, Bucci, Barbara, Raffa, Salvatore, Amendola, Donatella, Maggio, Roberta, Lardo, Pina, Petrangeli, Elisa, Torrisi, Maria Rosaria, Toscano, Vincenzo, Pugliese, Giuseppe, Stigliano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183165/ https://www.ncbi.nlm.nih.gov/pubmed/34108938 http://dx.doi.org/10.3389/fendo.2021.667798 |
Ejemplares similares
-
Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study
por: Cerquetti, Lidia, et al.
Publicado: (2019) -
Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment
por: Stigliano, Antonio, et al.
Publicado: (2012) -
Machine Learning-Based Texture Analysis in the Characterization of Cortisol Secreting vs. Non-Secreting Adrenocortical Incidentalomas in CT Scan
por: Maggio, Roberta, et al.
Publicado: (2022) -
p53 Stabilization Induces Cell Growth Inhibition and Affects IGF2 Pathway in Response to Radiotherapy in Adrenocortical Cancer Cells
por: Sampaoli, Camilla, et al.
Publicado: (2012) -
Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report
por: Stigliano, Antonio, et al.
Publicado: (2018)